{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:20:08Z","timestamp":1787664008218,"version":"build-2736575974"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The viral reservoir established after HIV-1 infection remains the primary barrier to curing HIV. Recent studies suggest that proviral HIV-1 DNA, low-level viral transcripts, and other reservoir-derived viral products may contribute to persistent innate immune activation and type I interferon (IFN-I)-related inflammatory programs. This sustained activation drives a state of chronic immune activation, which induces and maintains exhaustion in immune cells such as CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Exhaustion is characterized by loss of effector function and upregulation of inhibitory receptors (immune checkpoints), severely compromising the host\u2019s antiviral immune response. In this review, we systematically examine the molecular and cellular mechanisms by which the HIV-1 reservoir fuels immune exhaustion through the IFN-I signaling pathway. We further explore potential intervention targets along this pathway, providing a theoretical framework for the development of novel therapeutic strategies aimed at reservoir elimination or reversal of immune exhaustion.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1829548","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:33:33Z","timestamp":1787661213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistent IFN-I signaling associated with the HIV-1 reservoir fuels immune exhaustion and reveals therapeutic targets"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhihui","family":"Zhang","sequence":"first","affiliation":[{"name":"Henan Clinical Research Center of Infectious Diseases (AIDS), The Sixth People\u2019s Hospital of Zhengzhou","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Ren","sequence":"additional","affiliation":[{"name":"Henan Clinical Research Center of Infectious Diseases (AIDS), The Sixth People\u2019s Hospital of Zhengzhou","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Deng","sequence":"additional","affiliation":[{"name":"Henan Clinical Research Center of Infectious Diseases (AIDS), The Sixth People\u2019s Hospital of Zhengzhou","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Clinical Research Center of Infectious Diseases (AIDS), The Sixth People\u2019s Hospital of Zhengzhou","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Henan Clinical Research Center of Infectious Diseases (AIDS), The Sixth People\u2019s Hospital of Zhengzhou","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6952286","article-title":"Insights into the HIV-1 latent reservoir and strategies to cure HIV-1 infection","volume":"2022","author":"Bai","year":"2022","journal-title":"Dis Markers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1826361","article-title":"An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics","volume":"9","author":"Wang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05556-6","article-title":"HIV silencing and cell survival signatures in infected T cell reservoirs","volume":"614","author":"Clark","year":"2023","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/v13091751","article-title":"The splice of life: Does RNA processing have a role in HIV-1 persistence","volume":"13","author":"Pasternak","year":"2021","journal-title":"Viruses"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1016\/j.immuni.2024.11.002","article-title":"Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy","volume":"57","author":"Moskovljevic","year":"2024","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022928118","article-title":"Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination","volume":"118","author":"Lopez Angel","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012709","article-title":"Sustained immune activation and impaired epithelial barrier integrity in the ectocervix of women with chronic HIV infection","volume":"20","author":"Franz\u00e9n Boger","year":"2024","journal-title":"PloS Pathog"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v17020139","article-title":"The role of sustained type I interferon secretion in chronic HIV pathogenicity: Implications for viral persistence, immune activation, and immunometabolism","volume":"17","author":"Teer","year":"2025","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1736658","article-title":"Interferons in HIV-1 infection: mechanisms, antiviral potentials, and therapeutic challenges","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/v17081099","article-title":"Persistent type I interferon signaling impairs innate lymphoid cells during HIV-1 infection under suppressive ART","volume":"17","author":"Han","year":"2025","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159136","article-title":"Autophagy inducer rapamycin treatment reduces IFN-I\u2013mediated inflammation and improves anti\u2013HIV-1 T cell response in vivo","volume":"7","author":"Mu","year":"2022","journal-title":"JCI Insight"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab155","article-title":"Correlation between TIGIT expression on CD8+ T cells and higher cytotoxic capacity","volume":"224","author":"Blazkova","year":"2021","journal-title":"J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/v14030581","article-title":"Expression profile and biological role of immune checkpoints in disease progression of HIV\/SIV infection","volume":"14","author":"Sun","year":"2022","journal-title":"Viruses"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092227","article-title":"Immune checkpoint inhibitors in people living with HIV\/AIDS: Facts and controversies","volume":"10","author":"Castelli","year":"2021","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001887","article-title":"PD-1 expression in HIV-specific CD8+ T cells before antiretroviral therapy is associated with HIV persistence","volume":"80","author":"Ghiglione","year":"2019","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1865302","article-title":"HIV-1 cure strategies: Why CRISPR","volume":"21","author":"Atkins","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2025.100215","article-title":"Beyond monotherapy: Combination therapies for HIV-1 cure through joint application of neutralizing antibodies, genome editing, and reservoir management","volume":"4","author":"Mao","year":"2025","journal-title":"Infect Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001085","article-title":"Heterogeneity of HIV-1 latent reservoirs","volume":"133","author":"Zhao","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/COH.0000000000000835","article-title":"HIV-1 subtypes and latent reservoirs","volume":"19","author":"Ranga","year":"2024","journal-title":"Curr Opin HIV AIDS"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012822","article-title":"Transcriptomic HIV-1 reservoir profiling reveals a role for mitochondrial functionality in HIV-1 latency","volume":"21","author":"Man","year":"2025","journal-title":"PloS Pathog"},{"key":"B22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12879-020-4785-6","article-title":"HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: A correlation study","volume":"20","author":"Lyu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010254","article-title":"Sensor sensibility\u2014HIV-1 and the innate immune response","volume":"9","author":"Yin","year":"2020","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.molcel.2022.06.010","article-title":"Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA","volume":"82","author":"Yoh","year":"2022","journal-title":"Mol Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2022.09.007","article-title":"Two-step recognition of HIV-1 DNA in the cytosol","volume":"31","author":"Dopkins","year":"2023","journal-title":"Trends Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105632","article-title":"Validation of digital droplet PCR assays for cell-associated HIV-1 DNA, HIV-1 2-LTR circle, and HIV-1 unspliced RNA for clinical studies in HIV-1 cure research","volume":"170","author":"Reed","year":"2024","journal-title":"J Clin Virol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000691","article-title":"Visualization of HIV-1 reservoir: An imaging perspective","volume":"16","author":"Chapon","year":"2021","journal-title":"Curr Opin HIV AIDS"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1788994","article-title":"Persistent activation of monocytes\/macrophages and cell senescence in SIV-infected macaques on ART","volume":"17","author":"Chen","year":"2026","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1507530","article-title":"Heightened expression of type I interferon signaling genes in CD4+ T cells from acutely HIV-1\u2013infected women is associated with lower viral loads","volume":"15","author":"El-Badry","year":"2025","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013868","article-title":"HIV-1 derived oligonucleotides induce a type I IFN\/STING dependent immune suppression reversible by targeting IFNARI","volume":"22","author":"Svanberg","year":"2026","journal-title":"PloS Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02252-9","article-title":"Transcriptional insights into the CD8+ T cell response in mono-HIV and HCV infection","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528382","article-title":"Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling","volume":"16","author":"Park","year":"2025","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012063","article-title":"Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts","volume":"20","author":"Zhang","year":"2024","journal-title":"PloS Pathog"},{"key":"B34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s43556-025-00381-5","article-title":"Interferon signaling pathways in health and disease","volume":"6","author":"Wen","year":"2025","journal-title":"Mol BioMed"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155633","article-title":"Abnormalities of the type I interferon signaling pathway in lupus autoimmunity","volume":"146","author":"Gallucci","year":"2021","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14080802","article-title":"Mycobacterium tuberculosis modulates the expansion of terminally exhausted CD4+ and CD8+ T cells in individuals with HIV-TB co-infection","volume":"14","author":"Sharma","year":"2025","journal-title":"Pathogens"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103840","article-title":"Immune checkpoint blockade in HIV","volume":"76","author":"Gubser","year":"2022","journal-title":"eBioMedicine"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0453","article-title":"CD106 in tumor-specific exhausted CD8+ T cells mediates immunosuppression by inhibiting TCR signaling","volume":"84","author":"Naoi","year":"2024","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/1878-0261.13047","article-title":"Breast cancer metastasis: Immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression","volume":"16","author":"Rye","year":"2022","journal-title":"Mol Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2021.06.004","article-title":"Transcriptional regulation of T cell metabolism and metabolic control of T cell gene expression","volume":"70","author":"Veliz","year":"2021","journal-title":"Curr Opin Genet Dev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.20900\/immunometab20200020","article-title":"T cell metabolism in cancer immunotherapy","volume":"2","author":"Aksoylar","year":"2020","journal-title":"Immunometabolism"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1409238","article-title":"Tumor glucose metabolism and the T cell glycocalyx: Implication for T cell function","volume":"15","author":"Schuurmans","year":"2024","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157400","article-title":"Mitochondrial metabolism in T cell exhaustion","volume":"26","author":"Li","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/v17060774","article-title":"Finetuning type I interferon signaling to enhance T cell immunity in HIV infection","volume":"17","author":"Mu","year":"2025","journal-title":"Viruses"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451395","article-title":"TOX does not drive sepsis\u2010induced T\u2010cell exhaustion","volume":"55","author":"Qin","year":"2025","journal-title":"Eur J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049256","article-title":"Immune function and dysfunction are determined by lymphoid tissue efficacy","volume":"15","author":"Makris","year":"2022","journal-title":"Dis Model Mech"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2025.107111","article-title":"Dendritic cells: Key controllers of lymphoid tissue organization","volume":"278","author":"Calabr\u00f2","year":"2026","journal-title":"Immunol Lett"},{"key":"B48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: Immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.935800","article-title":"SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps","volume":"13","author":"Sertznig","year":"2022","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.07.025","article-title":"During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR\/DP\/DQ","volume":"2","author":"Ruggiero","year":"2015","journal-title":"EBioMedicine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2026.105264","article-title":"HIV reservoir dynamics according to the timing of antiretroviral therapy initiation or modification","volume":"56","author":"Gantner","year":"2026","journal-title":"Infect Dis Now"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656663","article-title":"IP-10 promotes latent HIV infection in resting memory CD4+ T cells via LIMK-cofilin pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011286","article-title":"The pathogenesis, molecular mechanisms, and therapeutic potential of the interferon pathway in systemic lupus erythematosus and other autoimmune diseases","volume":"22","author":"Ramaswamy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149575","article-title":"Altered increase in STAT1 expression and phosphorylation in severe COVID\u201019","volume":"52","author":"Rincon\u2010Arevalo","year":"2022","journal-title":"Eur J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl0368","article-title":"JAK\/STAT signaling pathway affects CCR5 expression in human CD4+ T cells","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1155\/mi\/3181200","article-title":"Targeting interferon\u2010gamma (IFN\u2010\u03b3)\u2010related signalling pathways in inflammatory bowel disease: Emerging inhibitors and therapeutic advances","volume":"2025","author":"Rahaman","year":"2025","journal-title":"Mediators Inflammation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00737","article-title":"Treating cancer in people with HIV","volume":"41","author":"Lurain","year":"2023","journal-title":"J Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp7302","article-title":"Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity","volume":"9","author":"Zhang","year":"2024","journal-title":"Sci Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.omto.2022.03.006","article-title":"IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity","volume":"25","author":"El-Sayes","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.chom.2021.04.014","article-title":"Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir","volume":"29","author":"Rajashekar","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002397","article-title":"Immune checkpoint inhibitors in people living with HIV: What about anti-HIV effects","volume":"34","author":"Abbar","year":"2020","journal-title":"AIDS"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.05.692491","article-title":"SP140 limits type I interferon\u2013driven pathology, preserving T cell motility and promoting resistance in tuberculosis","author":"Caouaille","year":"2025","journal-title":"BioRxiv Prepr"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000692","article-title":"Go\u201d, \u201cNo go,\u201d or \u201cWhere to go\u201d; does microbiota dictate T cell exhaustion, programming, and HIV persistence","volume":"16","author":"Shukla","year":"2021","journal-title":"Curr Opin HIV AIDS"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007573","article-title":"Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites","volume":"12","author":"Muijlwijk","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000438","article-title":"Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients","volume":"78","author":"Genshaft","year":"2023","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110810","article-title":"Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment","volume":"27","author":"Lim","year":"2024","journal-title":"iScience"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e8","article-title":"Interferon-driven metabolic reprogramming and tumor microenvironment remodeling","volume":"25","author":"Chang","year":"2025","journal-title":"Immune Netw"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac421","article-title":"Antibody and T cell subsets analysis unveils an immune profile heterogeneity mediating long-term responses in individuals vaccinated against SARS-CoV-2","volume":"227","author":"Agallou","year":"2023","journal-title":"J Infect Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451211","article-title":"Cytokine autoantibodies alter gene expression profiles of healthy donors","volume":"55","author":"Von Stemann","year":"2025","journal-title":"Eur J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.876660","article-title":"The interferon gamma-related long noncoding RNA signature predicts prognosis and indicates immune microenvironment infiltration in colon adenocarcinoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704965","article-title":"Interferon-induced transmembrane protein 3 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors","volume":"12","author":"Cai","year":"2021","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1576468","article-title":"TOX, through a glass, darkly","volume":"16","author":"Hogan","year":"2025","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12672-024-01412-3","article-title":"T cell exhaustion methylation signature drives differential immune responses in glioblastoma","volume":"15","author":"Chen","year":"2024","journal-title":"Discov Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9565","DOI":"10.1038\/s41598-025-94424-0","article-title":"Modulation of the tumor immune microenvironment by interferon regulatory factor 8 enhances immunotherapy in lung adenocarcinoma","volume":"15","author":"Huo","year":"2025","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/COH.0000000000000998","article-title":"Targeting the pDC\/IFN-I axis in HIV-1 immunotherapy","volume":"21","author":"Su","year":"2026","journal-title":"Curr Opin HIV AIDS"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.782852","article-title":"Antiviral responses in cancer: Boosting antitumor immunity through activation of interferon pathway in the tumor microenvironment","volume":"12","author":"Vitiello","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12943-023-01908-6","article-title":"A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state","volume":"22","author":"Van Lint","year":"2023","journal-title":"Mol Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2021.197","article-title":"Modulating oncolytic adenovirus immunotherapy by driving two axes of the immune system by expressing 4-1BBL and CD40L","volume":"33","author":"Lu","year":"2022","journal-title":"Hum Gene Ther"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005463","article-title":"Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination","volume":"11","author":"Carlson","year":"2023","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1829548\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:33:33Z","timestamp":1787661213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1829548\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":80,"alternative-id":["10.3389\/fimmu.2026.1829548"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1829548","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1829548"}}